Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Self-Report Tests of Personality01:22

Self-Report Tests of Personality

Self-report inventories are objective personality assessments that use multiple-choice items or numbered scales, typically ranging from 1 (strongly disagree) to 5 (strongly agree). They are often called Likert scales after Rensis Likert. These inventories are widely used due to their ease of administration and cost-effectiveness. One of the most prominent examples is the Minnesota Multiphasic Personality Inventory (MMPI), initially developed in the 1940s to assess abnormal personality traits.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and family engagement in adult and paediatric critical care research: A scoping review.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Enhancing continuity of care: Codevelopment of an intensive care unit transitions in care bundle.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Gender equality and equity in intensive care: an international Delphi consensus study.

Intensive care medicine·2026
Same author

Feasibility and Acceptability of a Patient- and Family-Oriented Approach to Pain Assessment in the Intensive Care Unit.

Nursing in critical care·2026
Same author

Patient and family perceptions of research coordinator attire in the intensive care unit: A cross-sectional survey-based study.

Journal of critical care·2026
Same author

Core sociodemographic data variables reported in Canadian intensive care unit studies: a scoping review.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2026
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

The multiple sclerosis depression rating scale.

Kirsten M Fiest1, Scott B Patten

  • 1Department of Community Health Sciences, University of Calgary, 3rd Floor TRW Building, 3280 Hospital Drive N.W., Calgary, AB, T2N 4Z6, Canada.

Expert Review of Neurotherapeutics
|October 9, 2012
PubMed
Summary
This summary is machine-generated.

Depression significantly impacts multiple sclerosis (MS) patients. A new scale, the Multiple Sclerosis Depression Rating Scale, aims to accurately measure depression in MS by addressing illness-specific symptoms.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Related Experiment Videos

Last Updated: May 18, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression is a common and debilitating comorbidity in multiple sclerosis (MS).
  • Existing depression scales may overestimate depressive symptoms in MS due to cognitive deficits and somatic symptoms inherent to the condition.
  • Misclassification of depression can lead to unnecessary clinical assessments and research bias.

Discussion:

  • The development of the Multiple Sclerosis Depression Rating Scale (MSDRS) addresses the limitations of current depression assessment tools in the MS population.
  • The MSDRS is designed to differentiate between core depressive symptoms and those exacerbated by MS-related factors.
  • Accurate depression measurement is crucial for effective patient management and research integrity in MS.

Key Insights:

  • The MSDRS offers a more precise method for evaluating depression in individuals with multiple sclerosis.
  • This new scale helps mitigate the risk of false-positive depression ratings caused by MS-specific symptoms.
  • Improved diagnostic accuracy facilitates targeted interventions and reduces healthcare resource waste.

Outlook:

  • The MSDRS has the potential to enhance clinical screening protocols for depression in MS.
  • Wider adoption of the MSDRS could improve the quality of research on depression and MS.
  • Further validation studies will confirm the utility of the MSDRS across diverse MS populations.